Conduit Pharmaceuticals Inc. (CDT)

Conduit Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.07	4.23	-	-
Cash & Short-Term Investments	0.15	4.23	-	-
Prepaid Expenses	0.51	1.51	-	-
Total Current Assets	1.4	5.73	-	-
Long-Term Deferred Charges	-	-	0.01	-
Other Long-Term Assets	1.26	1.49	-	-
Total Assets	2.99	7.22	0.01	-
Accounts Payable	1.9	0.22	-	-
Accrued Expenses	1.79	0.6	2.58	2.23
Current Portion of Long-Term Debt	2.29	0.99	0.18	-
Other Current Liabilities	5.74	-	1.42	0.01
Total Current Liabilities	11.98	1.8	4.18	2.24
Long-Term Debt	-	-	1.84	0.75
Long-Term Unearned Revenue	-	-	4.08	2.96
Other Long-Term Liabilities	0.02	5.88	-	-
Total Liabilities	12.11	7.68	10.09	5.94
Common Stock	0.01	0.01	0.01	-
Additional Paid-In Capital	17.3	10.42	-	-
Retained Earnings	-26.7	-11.3	-10.77	-5.88
Comprehensive Income & Other	0.27	0.41	0.68	-0.07
Shareholders' Equity	-9.12	-0.46	-10.09	-5.94
Total Liabilities & Equity	2.99	7.22	0.01	-
Total Debt	2.67	0.99	2.01	0.75
Net Cash (Debt)	-2.51	3.24	-2.01	-0.75
Net Cash Per Share	-0.03	0.05	-0.05	-
Filing Date Shares Outstanding	102.85	73.83	-	-
Total Common Shares Outstanding	96	73.83	-	-
Working Capital	-10.58	3.93	-4.18	-2.24
Book Value Per Share	-0.09	-0.01	-	-
Tangible Book Value	-9.12	-0.46	-10.09	-5.94
Tangible Book Value Per Share	-0.09	-0.01	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.